Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia
February 2016
in “
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
”
TLDR A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.
In 2016, Goren A and colleagues explored the clinical utility and validity of a sulfotransferase activity assay in guiding treatment for androgenetic alopecia (AGA). The researchers conducted an assay procedure on plucked anagen hairs from AGA patients, immersing them in a solution and measuring the optical absorbance at 405nm with a spectrophotometer. They found that a value of less than 0.4 absorbance units indicated low follicular sulfotransferase activity. The assay was able to predict response to 5% topical minoxidil therapy with a sensitivity of 100% and a specificity of 71%. This test could potentially rule out nonresponders to minoxidil, reducing the side effects, emotional stress, and expense associated with using an ineffective drug.